Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000031.xml
Download PDF
Klin Monbl Augenheilkd 2023; 240(04): 566-568
DOI: 10.1055/a-2004-5504
DOI: 10.1055/a-2004-5504
Der interessante Fall
When Your Patient Needs New Glasses Every Day
Wenn die Patientin jeden Tag eine neue Brille benötigtAuthors
Background
Inflammatory eye diseases have numerous etiologies. Here, we report on a rare case of intermittent bilateral myopic shifts in a healthy, young patient with initially no clinical manifestation of the underlying inflammatory cause.
Publication History
Received: 14 October 2022
Accepted: 21 December 2022
Article published online:
25 April 2023
© 2023. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Sugiura S. Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol 1978; 22: 9-35
- 2 Feldman BH, OʼKeefe GD, Salcedo HR. et al. Vogt-Koyanagi-Harada Disease. Accessed September 27, 2022 at: http://eyewiki.aao.org
- 3 Standardization of Uveitis Nomenclature (SUN) Working Group. Classification criteria for Vogt-Koyanagi-Harada disease. Am J Ophthalmol 2021; 228: 205-211
- 4 Rao NA, Sukavatcharin S, Tsai JH. Vogt-Koyanagi-Harada disease diagnostic criteria. Int Ophthalmol 2007; 27: 195-199
- 5 Rathiam SR, Vijayalakshmi P, Namperumalsamy P. et al. Vogt–Koyanagi–Harada syndrome in children. Ocul Immunol Inflam 1998; 6: 155-161
- 6 Paredes I, Ahmed M, Foster C. Immunomodulatory therapy for Vogt-Koyanagi-Harada patients as first-line therapy. Ocul Immunol Inflamm 2006; 14: 87-90
- 7 Lai TYY, Chan RPS, Chan CKM. et al. Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease. Eye (Lond) 2009; 23: 543-548
- 8 Biswas J, Rao NA. Management of Intraocular Inflammation. In: Ryan SJ. ed. Retina. Vol. 2. St. Louis: Mosby-Year Book; 1994: 1061-1069
- 9 Rao NA, Blackman HJ, Franklin RM. et al. Intraocular Inflammation and Uveitis. In: Course Book. Basic and Clinical Science Course 1998 – 1999. San Francisco: American Academy of Ophthalmology; 1998: 76-79
- 10 Paredes I, Ahmed M, Foster CS. Immunomodulatory therapy for Vogt-Koyanagi-Harada patients as first-line therapy. Ocul Immunol Inflamm 2006; 14: 87-90
- 11 Yang P, Wang H, Zhou H. et al. [Therapeutic regimen in Vogt Koyanagi Harada syndrome]. Zhonghua Yan Ke Za Zhi 2002; 38: 196-199